November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
According to market projections, the biospecimen procurement market sector is expected to grow from USD 85.94 million in 2024 to USD 380.42 million by 2034, reflecting a CAGR of 16.04%. Biospecimen procurement is increasing due to the increased need for high-quality biospecimens in various life science R&D. Similarly, the demand for human biosp...
November 01, 2025
According to market projections, the phosphoramidite sector is expected to grow from USD 1.2 billion in 2024 to USD 2.45 billion by 2034, reflecting a CAGR of 7.4%. Phosphoramidite is an essential part of DNA synthesis, which is used in various therapeutics, genetic engineering, and research, and has promoted the growth of the phosphoramidite marke...
November 01, 2025
Market insights predict the global single nucleotide polymorphism (SNP) genotyping industry will increase from USD 6.48 billion in 2024 to USD 19.48 billion by 2034, achieving a CAGR of 11.7%. The single nucleotide polymorphism (SNP) genotyping market is expanding due to rising genetic disorders as well as increasing developments in precision medic...
November 01, 2025
Based on market forecasts, the global whole genome sequencing market, projected at USD 2.15 billion in 2024, is expected to reach USD 15.96 billion by 2034, growing at a CAGR of 22.2% over the forecast period. The market is growing due to increasing demand for precision medicine and early disease detection. Failing costs and faster sequencing techn...
November 01, 2025
Projections indicate that, DNA read, write, and edit industry is projected to rise from USD 7.35 billion in 2024 to USD 26.46 billion by 2034, reflecting a CAGR of 13.63% over the next decade. The DNA read, write, and edit market is expanding due to increasing demand for personalized medication as well as rising gene therapies. North America led th...
November 01, 2025
Market insights predict, the lentiviral vector industry is expected to grow from USD 360 million in 2024 to USD 1943.24 million by 2034, driven by a CAGR of 18.56%. The lentiviral vector market is expanding due to growing awareness as well as rising demand for T-cell therapies. North America led the market due to the presence of the advanced health...
November 01, 2025
According to forecasts, the global GMP Plasmid DNA manufacturing market will grow from USD 250 million in 2024 to USD 608.57 million by 2034, with an expected CAGR of 9.34%. The GMP plasmid DNA manufacturing market is growing due to the growing demand for personalized medicine. North America is dominating the market due to strict regulations regard...
November 01, 2025
According to forecasts, the global cell-free protein expression market will grow from USD 315.03 million in 2024 to USD 716.26 million by 2034, with an expected CAGR of 8.63%. The market is growing due to faster and more efficient protein production compared to traditional methods. Advances in biotechnology and automation are boosting system capabi...
November 01, 2025
Market insights predict, the north america next generation sequencing industry is expected to grow from USD 5.08 billion in 2024 to USD 36.87 billion by 2034, driven by a CAGR of 21.93%. North America is growing due to technological advancements and investments in the biotechnology industry....
November 01, 2025
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com